The tumorigenic activity of SIRT2 in HCC has been related to EMT induction by direct targeting of the protein kinase B/glycogen synthase kinase (Akt/GSK)3-β/β-catenin signaling pathway [69]. The gene discussed is AKT1; the disease is hepatocellular carcinoma.